Fasoracetam is the newest racetam nootropic that is under development as a possible ADHD treatment. It can also assuage anxiety, reduce depression, and promote memory and cognition.
In 2015, the United States Food and Drug Administration’s Investigational New Drug program, which permits the developers to commence human clinical tests and supply the drug across other states, accepted fasoracetam as beneficial for memory enhancement.
Human studies on fasoracetam are positive and show that it can effectively cure a specific type of childhood ADHD. Further studies on animals and anecdotal evidence from users indicate that it may also promote memory, relieve depression, and help with the withdrawal of other drugs.
Note “Fasoracetam is not officially approved for use by the USFDA, it’s categorized as a research chemical which is not intended for use by humans”.
Benefits of Fasoracetam
There is not a lot of research information on fasoracetam available to the public. However, it’s quickly gaining recognition in the community of nootropics with many users giving rave reviews about its benefits.
Some of its benefits include:
In one research study conducted on animals, fasoracetam effectively reduced levels of artificially induced memory loss and amnesia.
As stated before, there is no data available publicly for similar experiments on humans. However, several users report that they experienced considerable memory enhancement when using it.
Like all other racetam nootropics, fasoracetam increases levels of acetylcholine, the neurotransmitter that facilitates memory, learning, and cognitive functions.
Other reports indicate fasoracetam may improve mood. It may also reduce anxiety and help with depression by affecting two of the brain’s most potent mood-influencing chemicals, glutamate and gamma-aminobutyric acid (GABA).
It simultaneously up-regulates GABA- an inhibitory neurotransmitter, and suppress the over generation of the excitatory neurotransmitter glutamate. Fasoracetam gives users a smooth feeling of enhanced mood and calmness.
The above claims are purely anecdotal as there are no publicly available research results regarding fasoracetam’s effect on anxiety, depression, or mood.
However, the tests on animals supports these anecdotal reports.
3. ADHD Treatment
Fasoracetam’s potential for ADHD treatment is one of the few public research reports available to the public.
The study, which was conducted on 30 subjects in the age groups between 12 and 17, lead to the conclusion that there fasoracetam is effective in treating ADHD among the adolescents who showed a distinct mutation in the glutamatergic gene network. The mutation is strongly linked with ADHD and is present in a considerable percentage of adolescents suffering from that disorder.
The subjects who used fasoracetam during the five weeks of the study showed improvement during the trial. The reduction in ADHD symptoms endured in the post-trial testing, not one of the study participants showed the development of either tolerance or dependence.
Fasoracetam remains new and an experimental drug, but has so far commanded a strong following in the nootropic community.
Several users find it’s an effective cognitive facilitator which further helps with anxiety, sleep issues, depression and a shortage of motivation.
This nootropic is safe and well tolerated when used responsibly.